معرفی
Michelle Chew is a Professor at the Department of Biomedical and Clinical Sciences (BKV), affiliated with the Division of Clinical Chemistry and Pharmacology (KKF) at Linköping University. She belongs to the Faculty of Medicine and Health Sciences. Her research focuses on cardiac injury post-anaesthesia, brain dynamics during anaesthesia, sepsis-induced cardiomyopathy, and critical care medicine. She collaborates with interdisciplinary teams across clinical chemistry, pharmacology, and forensic sciences. Recent work includes studies on post-surgery cardiac biomarkers, hypotension prediction in critical care, and outcomes of tracheostomy in severe COVID-19 patients.
Key research areas include circulatory dysfunction, inflammation, and cardio-metabolic risk factors through the LiU CircM strategic network. Her publications in 2025 span European Heart Journal, Intensive Care Medicine, and Resuscitation, reflecting expertise in critical care and anaesthesiology. Grants include SEK 13 million for forensic AI research, though no explicit awards are listed here.
Michelle advises within her division and contributes to clinical education. Her team’s work bridges basic science and clinical practice, addressing unresolved questions in anaesthesia’s physiological impacts and critical care interventions. She is actively engaged in translational research to improve patient outcomes via biomarkers and diagnostic innovations.
